Here are four news updates on key gastroenterology and endoscopy companies.
EndoChoice has a consensus revenue estimate of $74.51 million for fiscal year 2015.
EndoChoice is collaborating with De Lage Landen Financial Services to create a new financing option for customers interested in its Fuse Endoscopy system.
Clinical-stage biopharmaceutical company Spring Bank Pharmaceutical appointed Nezam Afdhal, MD, CMO.
Olympus introduced its CleverCut3V Distal Wireguided sphincterotome.